The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Regression of Atherosclerosis Induced by Liver-Directed Gene Transfer of Apolipoprotein A-I in Mice
Open accessAbstract
Background —The ability of apolipoprotein (apo)A-I to induce regression of preexisting atherosclerotic lesions has not been determined, and a mouse model of atherosclerosis regression has not yet been reported. Methods and Results —LDL receptor–deficient mice were fed a western-type diet for 5 weeks to induce atherosclerotic lesions. A second-generation recombinant adenovirus encoding human apoA-I or a control adenovirus were injected intravenously in order to express apoA-I in the liver. Three days after injection, total apoA-I levels in mice injected with the apoA-I–expressing adenovirus were 216±16.0 mg/dL, compared with 68.0±3.0 mg/dL in control virus–injected mice ( P <0.001). HDL cholesterol levels in mice injected with the AdhapoA-I vector 7 days after injection were 189±21.0 mg/dL, compared with 123±8.0 mg/dL in control virus-injected mice ( P <0.02). Total and non-HDL cholesterol levels did not differ between the 2 groups. Atherosclerotic lesion area was quantified by en face analysis of the aorta and cross-sectional analysis of the aortic root. Compared with baseline mice, atherosclerosis progressed in mice injected with the control adenovirus. In contrast, in mice expressing apoA-I compared with baseline mice, total en face aortic lesion area was reduced by 70% and aortic root lesion was reduced by 46%. Expression of apoA-I was associated with a significant reduction in the fraction of lesions occupied by macrophages and macrophage-derived foam cells. Conclusions —Liver-directed gene transfer of human apoA-I resulted in significant regression of preexisting atherosclerotic lesions in LDL receptor–deficient mice as assessed by 2 independent methods.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Role of oxidized low density lipoprotein in atherogenesis.
Witztum, J. L., & Steinberg, D. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115499 · Cited by 2,675
ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree.
Nakashima, Y., Plump, A. S., Raines, E. W., Breslow, J. L., & Ross, R. (1994) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.14.1.133 · Cited by 1,693
High-Density Lipoprotein — The Clinical Implications of Recent Studies
Desforges, J. F., Gordon, D. J., & Rifkind, B. M. (1989) · New England Journal of Medicine · doi:10.1056/nejm198911093211907 · Cited by 1,547
Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis
Shih, D. M., Gu, L., Xia, Y.-R., Navab, M., Li, W.-F., Hama, S., Castellani, L. W., Furlong, C. E., Costa, L. G., Fogelman, A. M., et al. (1998) · Nature · doi:10.1038/28406 · Cited by 1,078
Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI
Rubin, E. M., Krauss, R. M., Spangler, E. A., Verstuyft, J. G., & Clift, S. M. (1991) · Nature · doi:10.1038/353265a0 · Cited by 986
High-Density Lipoproteins Inhibit Cytokine-Induced Expression of Endothelial Cell Adhesion Molecules
Cockerill, G. W., Rye, K.-A., Gamble, J. R., Vadas, M. A., & Barter, P. J. (1995) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.15.11.1987 · Cited by 783
Badimon, J. J., Badimon, L., & Fuster, V (1990) · Journal of Clinical Investigation · doi:10.1172/jci114558 · Cited by 764
Plasma high density lipoproteins. Metabolism and relationship to atherogenesis.
Tall, A. R. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114722 · Cited by 652
Springer, T., Galfrè, G., Secher, D. S., & Milstein, C. (1978) · European Journal of Immunology · doi:10.1002/eji.1830080802 · Cited by 576
Plump, A. S., Scott, C. J., & Breslow, J. L. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.20.9607 · Cited by 568
Metlay, J. P., Witmer-Pack, M. D., Agger, R., Crowley, M. T., Lawless, D., & Steinman, R. M. (1990) · The Journal of experimental medicine · doi:10.1084/jem.171.5.1753 · Cited by 555
Tangirala, R. K., Rubin, E. M., & Palinski, W. (1995) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39713-3 · Cited by 514
Self-citationGoldbourt, U., Yaari, S., & Medalie, J. H. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.17.1.107 · Cited by 391
Apolipoprotein AI transgene corrects apolipoprotein E deficiency-induced atherosclerosis in mice.
Pászty, C., Maeda, N., Verstuyft, J., & Rubin, E. M. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117412 · Cited by 374
Increased atherosclerosis in mice reconstituted with apolipoprotein E null macrophages
Fazio, S., Babaev, V. R., Murray, A. B., Hasty, A. H., Carter, K. J., Gleaves, L. A., Atkinson, J. B., & Linton, M. F. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.9.4647 · Cited by 295
HDL Cholesterol Predicts Coronary Heart Disease Mortality in Older Persons
Corti, M.-C. (1995) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1995.03530070037026 · Cited by 285
Bellosta, S., Mahley, R. W., Sanan, D. A., Murata, J., Newland, D. L., Taylor, J. M., & Pitas, R. E. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118271 · Cited by 284
Hayek, T., Masucci-Magoulas, L., Jiang, X., Walsh, A., Rubin, E., Breslow, J. L., & Tall, A. R. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118255 · Cited by 265
Protection Against Atherogenesis in Mice Mediated by Human Apolipoprotein A-IV
Duverger, N., Tremp, G., Caillaud, J.-M., Emmanuel, F., Castro, G., Fruchart, J.-C., Steinmetz, A., & Denèfle, P. (1996) · Science · doi:10.1126/science.273.5277.966 · Cited by 246
Reichl, D., & Miller, N. E. (1989) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.9.6.785 · Cited by 237
Duverger, N., Kruth, H., Emmanuel, F., Caillaud, J.-M., Viglietta, C., Castro, G., Tailleux, A., Fievet, C., Fruchart, J. C., Houdebine, L. M., et al. (1996) · Circulation · doi:10.1161/01.cir.94.4.713 · Cited by 225
Familial hyper-alpha-lipoproteinemia: Studies in eighteen kindreds
Glueck, C. J., Fallat, R. W., Millett, F., Gartside, P., Elston, R. C., & Go, R. C. P. (1975) · Metabolism · doi:10.1016/0026-0495(75)90063-3 · Cited by 206
HDL and ApoA Prevent Cell Death of Endothelial Cells Induced by Oxidized LDL
Suc, I., Escargueil-Blanc, I., Troly, M., Salvayre, R., & Nègre-Salvayre, A. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.17.10.2158 · Cited by 204
Miyazaki, A., Sakuma, S., Morikawa, W., Takiue, T., Miake, F., Terano, T., Sakai, M., Hakamata, H., Sakamoto, Y.-I., Naito, M., et al. (1995) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.15.11.1882 · Cited by 191
Huang, Y., von Eckardstein, A., Wu, S., Maeda, N., & Assmann, G. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.5.1834 · Cited by 181
Cohen, R. D., Castellani, L. W., Qiao, J. H., Van Lenten, B. J., Lusis, A. J., & Reue, K. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119358 · Cited by 165
Somatic Gene Transfer of Human ApoA-I Inhibits Atherosclerosis Progression in Mouse Models
Benoit, P., Emmanuel, F., Caillaud, J. M., Bassinet, L., Castro, G. R., Gallix, P., Fruchart, J., Branellec, D., Denèfle, P., & Duverger, N. (1999) · Circulation · doi:10.1161/01.cir.99.1.105 · Cited by 147
Liu, A. C., Lawn, R. M., Verstuyft, J. G., & Rubin, E. M. (1994) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39932-6 · Cited by 117
Hoeg, J. M., Vaisman, B. L., Demosky, S. J., Meyn, S. M., Talley, G. D., Hoyt, R. F., Feldman, S. H., Bérard, A. M., Sakai, N., Wood, D. R., et al. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.8.4396 · Cited by 116
Effects of Intravenous Infusion of Lipid-Free Apo A-I in Humans
Nanjee, M. N., Crouse, J. R., King, J. M., Hovorka, R., Rees, S. E., Carson, E. R., Morgenthaler, J. ‐., Lerch, P., & Miller, N. E. (1996) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.16.9.1203 · Cited by 100
Geest, B. D., Zhao, Z., Collen, D., & Holvoet, P. (1997) · Circulation · doi:10.1161/01.cir.96.12.4349 · Cited by 99
Apolipoprotein A-I decreases neutrophil degranulation and superoxide production.
Wd, B., Dohlman, J. G., Venkatachalapathi, Y. V., Pillion, D. J., Koopman, W., Segrest, J., & Anantharamaiah, G. M. (1991) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41894-2 · Cited by 98
Role of high density lipoproteins in the regression of atherosclerosis.
Badimon, J. J., Fuster, V., & Badimón, L. (1992) · PubMed · Cited by 91
Hypoalphalipoproteinemia (low high density lipoprotein) as a risk factor for coronary heart disease
Vega, G. L., & Grundy, S. M. (1996) · Current Opinion in Lipidology · doi:10.1097/00041433-199608000-00007 · Cited by 91
Unravelling high density lipoprotein-apolipoprotein metabolism in human mutants and animal models
Rader, D. J., & Ikewaki, K. (1996) · Current Opinion in Lipidology · doi:10.1097/00041433-199606000-00002 · Cited by 59
Self-citationGeneration of analytic plasma lipoprotein profiles using two prepacked superose 6B columns
Gerdes, L. U., Gerdes, C., Klausen, I. C., & Færgeman, O. (1992) · Clinica Chimica Acta · doi:10.1016/0009-8981(92)90348-t · Cited by 44
Pharmacology of apolipoprotein A-l
Andersson, L. (1997) · Current Opinion in Lipidology · doi:10.1097/00041433-199708000-00006 · Cited by 29
Tsukamoto, K., Hiester, K. G., Smith, P., Usher, D. C., Glick, J. M., & Rader, D. J. (1997) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37161-3 · Cited by 29
Self-citationHuang, Y., Zhu, Y., Langer, C., Raabe, M., Wu, S., Wiesenhütter, B., Seedorf, U., Maeda, N., Assmann, G., & von Eckardstein, A. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.10.2010 · Cited by 24
Cited by
Glass, C. K., & Witztum, J. L. (2001) · Cell · doi:10.1016/s0092-8674(01)00238-0 · Cited by 3,051
HDL and cardiovascular disease
Rader, D. J., & Hovingh, G. K. (2014) · The Lancet · doi:10.1016/s0140-6736(14)61217-4 · Cited by 870
Self-citationvon Eckardstein, A., Nofer, J.-R., & Assmann, G. (2001) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.21.1.13 · Cited by 695
Rayner, K. J., Sheedy, F. J., Esau, C. C., Hussain, F. N., Temel, R. E., Parathath, S., van Gils, J. M., Rayner, A. J., Chang, A. N., Suarez, Y., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci57275 · Cited by 690
Molecular regulation of HDL metabolism and function: implications for novel therapies
Rader, D. J. (2006) · Journal of Clinical Investigation · doi:10.1172/jci30163 · Cited by 599
Self-citation
Metadata
- Authors
- Tangirala, R. K., Tsukamoto, K., Chun, S. H., Usher, D., Puré, E., & Rader, D. J.
- Venue
- Circulation
- Published
- 1999-10-26
- Volume
- 100
- Issue
- 17
- Pages
- 1816-1822
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2141907642
- Cited by
- 358
- References
- 39
- FWCI
- 21.08
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.